These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29645073)

  • 1. [Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
    Soto-Cabrera E; Villamil-Osorio LV; Garcia-Luna RC; Carrera-Pineda R
    Rev Neurol; 2018 Apr; 66(8):286-288. PubMed ID: 29645073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial lesion increase under anti-tuberculous therapy.
    Alay H; Albayrak A
    Rev Soc Bras Med Trop; 2020; 53():e20200112. PubMed ID: 32491102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Onset of neurological symptoms during tuberculosis treatment: description of two cases].
    Arquinio L; García-Gasalla M; Losada I; Sarasibar H
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):753-5. PubMed ID: 20541290
    [No Abstract]   [Full Text] [Related]  

  • 4. Optic neuropathy and perichiasmal tuberculomas associated with Mycobacterium tuberculosis meningitis in pregnancy.
    Yeh S; Cunningham MA; Patronas N; Foroozan R
    Can J Ophthalmol; 2009 Dec; 44(6):713-5. PubMed ID: 20029496
    [No Abstract]   [Full Text] [Related]  

  • 5. Present chemotherapy for tuberculosis.
    Dutt AK; Stead WW
    J Infect Dis; 1982 Nov; 146(5):698-704. PubMed ID: 6813386
    [No Abstract]   [Full Text] [Related]  

  • 6. Paradoxical vision loss associated with optochiasmatic tuberculoma in tuberculous meningitis: a report of 8 patients.
    Sinha MK; Garg RK; Anuradha HK; Agarwal A; Parihar A; Mandhani PA
    J Infect; 2010 Jun; 60(6):458-66. PubMed ID: 20346972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical growth of presumed optochiasmatic tuberculomas following medical therapy.
    Joseph M; Mendonca TM; Vasu U; Nithyanandam S; Mathew T
    JAMA Ophthalmol; 2013 Nov; 131(11):1463-7. PubMed ID: 24030820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse pachymeningitis due to Mycobacterium tuberculosis: a case report and review of the literature.
    Khawcharoenporn T; Apisarnthanarak A; Apisarnthanarak P; Rakskul P; Warnnissorn N; Kiratisin P; Mundy LM
    Hawaii Med J; 2008 Apr; 67(4):100-3. PubMed ID: 18524144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis.
    Garg RK; Paliwal V; Malhotra HS
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):719-29. PubMed ID: 21905782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of paradoxical response in pediatric tubercular meningitis with methylprednisolone.
    Nema N; Verma A; Singh K; Mehar V
    Middle East Afr J Ophthalmol; 2014; 21(2):189-92. PubMed ID: 24791114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical response to antitubercular drugs.
    Kumar S; Puri V; Mehndiratta MM; Gupta S; Bhutani A; Sharma C
    Indian J Pediatr; 1995; 62(6):695-701. PubMed ID: 10829946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
    Ruggeri C; Valenzise M; Alosi MM; Scibilia G; Wasniewska M
    Minerva Pediatr; 2005 Oct; 57(5):329-32. PubMed ID: 16205620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anhelation due to formation of tuberculomas at the medulla oblongata during chemotherapy of tuberculous meningitis.
    Ge P; Zhang X; Zhong Y; Bian X; Fu S; Luo Y
    Neurol Neurochir Pol; 2012; 46(5):501-5. PubMed ID: 23161196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optochiasmatic tuberculomas: a vision-threatening paradoxical response in tuberculous meningitis.
    Wani NA; Khan N; Kosar T; Qayum A
    Turk Neurosurg; 2012; 22(2):246-9. PubMed ID: 22437303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculosis control programme guidelines--treatment regimens.
    Durrheim DN; Belt EL
    S Afr Med J; 1996 Oct; 86(10):1293-4. PubMed ID: 8955740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment].
    Rabar D; Issartel B; Petiot P; Boibieux A; Chidiac C; Peyramond D
    Presse Med; 2005 Jan; 34(1):32-4. PubMed ID: 15685096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fulminant hepatitis during the therapy for tuberculous meningitis].
    Garavelli PL
    Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
    Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
    Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Complete Triad: Horner's Syndrome in Tuberculous Meningitis.
    Bongomin F; Khan SA; Oravec T
    Am J Med Sci; 2020 Aug; 360(2):204-205. PubMed ID: 32317170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.